Brookdale Senior Living (BKD) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
30 Apr, 2026Executive summary
Annual meeting scheduled for June 22, 2026, at company headquarters in Brentwood, Tennessee.
Proxy materials, including the notice, proxy statement, and annual report, are available online and by request.
Shareholders of record as of April 24, 2026, are eligible to vote.
Voting matters and shareholder proposals
Election of nine directors is on the agenda, with specific nominees listed.
Advisory vote on named executive officer compensation (say-on-pay) is included.
Ratification of Ernst & Young LLP as independent registered public accounting firm for 2026.
Proxies may vote on other business arising at the meeting or any adjournments.
Board of directors and corporate governance
Board recommends voting FOR all three proposals on the agenda.
Nine director nominees are presented for election.
Latest events from Brookdale Senior Living
- Director elections, executive pay, and auditor ratification headline the 2026 annual meeting.BKD
Proxy filing30 Apr 2026 - Record 2025 EBITDA and occupancy growth set the stage for robust 2026 performance.BKD
Q4 202510 Apr 2026 - Operational focus, targeted CapEx, and market-driven M&A support growth amid strong demand.BKD
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Q2 saw 20% Adjusted EBITDA growth, higher occupancy, but a wider net loss on higher costs.BKD
Q2 20241 Feb 2026 - 2026 targets $502–$516M Adjusted EBITDA and 8–9% RevPAR growth, led by operational transformation.BKD
Investor Day 202630 Jan 2026 - Q3 2024 delivered 15% EBITDA growth, higher occupancy, and $610M in acquisitions pending.BKD
Q3 202415 Jan 2026 - Strategic acquisitions, strong occupancy, and HealthPlus expansion drive positive 2025 outlook.BKD
Stephens 26th Annual Investment Conference | NASH202413 Jan 2026 - Accelerating occupancy, strong cash flow, and innovation position for sustained growth.BKD
Barclays 27th Annual Global Healthcare Conference26 Dec 2025 - 2024 results beat guidance; 2025 targets 11%-15% EBITDA growth and positive cash flow.BKD
Q4 202415 Dec 2025